Establishment Labs Holdings Inc (ESTA) - Total Assets
Based on the latest financial reports, Establishment Labs Holdings Inc (ESTA) holds total assets worth $351.93 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Establishment Labs Holdings Inc - Total Assets Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's total assets have evolved over time, based on quarterly financial data. Also see ESTA market cap for the company's overall valuation and market capitalisation.
Establishment Labs Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2025)
Establishment Labs Holdings Inc's total assets of $351.93 Million consist of 70.0% current assets and 30.0% non-current assets. Review total liabilities of Establishment Labs Holdings Inc to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 21.2% |
| Accounts Receivable | $77.50 Million | 21.7% |
| Inventory | $85.61 Million | 24.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $9.94 Million | 2.8% |
| Goodwill | $1.21 Million | 0.3% |
Asset Composition Trend (2016–2025)
This chart illustrates how Establishment Labs Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See Establishment Labs Holdings Inc share price for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Establishment Labs Holdings Inc's current assets represent 70.0% of total assets in 2025, an increase from 42.4% in 2016.
- Cash Position: Cash and equivalents constituted 21.2% of total assets in 2025, up from 1.6% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, a decrease from 7.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 24.0% of total assets.
Establishment Labs Holdings Inc Competitors by Total Assets
Key competitors of Establishment Labs Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
TransMedics Group Inc
NASDAQ:TMDX
|
USA | $1.46 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.20 Billion |
|
Hangzhou AGS MedTech Co. Ltd. A
SHG:688581
|
China | CN¥2.70 Billion |
|
Nanjing Vishee Medical Technology Co Ltd
SHG:688580
|
China | CN¥1.79 Billion |
Establishment Labs Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.84 | 2.84 | 4.10 |
| Quick Ratio | 2.52 | 1.67 | 3.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $183.17 Million | $148.43 Million | $94.25 Million |
Establishment Labs Holdings Inc - Advanced Valuation Insights
This section examines the relationship between Establishment Labs Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 102.92 |
| Latest Market Cap to Assets Ratio | 5.96 |
| Asset Growth Rate (YoY) | 3.0% |
| Total Assets | $357.17 Million |
| Market Capitalization | $2.13 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Establishment Labs Holdings Inc's assets at a significant premium (5.96x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: Establishment Labs Holdings Inc's assets grew by 3.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Establishment Labs Holdings Inc (2016–2025)
The table below shows the annual total assets of Establishment Labs Holdings Inc from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $357.17 Million | +2.98% |
| 2024-12-31 | $346.83 Million | +29.11% |
| 2023-12-31 | $268.64 Million | +27.28% |
| 2022-12-31 | $211.06 Million | +51.27% |
| 2021-12-31 | $139.53 Million | -10.78% |
| 2020-12-31 | $156.39 Million | +34.20% |
| 2019-12-31 | $116.53 Million | -0.04% |
| 2018-12-31 | $116.57 Million | +104.17% |
| 2017-12-31 | $57.09 Million | +93.14% |
| 2016-12-31 | $29.56 Million | -- |
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products… Read more